Women with Autoimmune Thyroiditis Taking Levothyroxine During Pregnancy: Is Iodine Supplementation Needed?
Nutrients · 2025
DOI: 10.3390/nu17030542 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, 2025. Verfasst von Simona Censi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35121 Padua, Italy. Hauptthemen laut MEDLINE: Iodine, Thyroxine, Thyroiditis, Autoimmune, Dietary Supplements. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Iodine is fundamental for the synthesis of thyroid hormones, which play a central role in foetal neurological development. The need for an iodine-containing supplement (ICS) in L-T4-treated women during pregnancy is still a subject of debate. Aim of the Study: The aim of the study is to investigate the iodine status in women with autoimmune thyroiditis (AT) who have or have not been treated with L-T4.
Methods
This was a cross-sectional, observational study involving pregnant women with AT, treated with/without L-T4. Upon enrolment, women provided a urine sample (to measure the urinary iodine concentration (UIC), which was normalised to urinary creatinine values (UI/Creat)), and completed a questionnaire. TSH, FT4, and neonatal TSH were also obtained.
Results
Among women taking an ICS, 74.1% had a UI/Creat level ≥ 150 μg/g, compared with only 46.2% of those not taking an ICS (p = 0.03). Among L-T4 users only, a UI/Creat level ≥ 150 μg/g was more frequent in ICS users than in non-ICS users (72.8% vs. 41.7%) (p = 0.03). In the multivariate analysis, ICS use was the only independent variable for UI/Creat ≥ 150 μg/g (OR: 3.4; CI: 1.1–10.9) (p = 0.04). There was a tendency towards higher UI/Creat levels as the L-T4 (µg/Kg) dosage increased, although no correlation was found. Newborns of women taking an ICS were found to have elevated neonatal TSH (2.8 mIU/L vs. 1.7 mIU/L) (p = 0.04). All newborns with a TSH >5 mUI/L were those of women taking supplements.
Conclusions
Women with AT taking L-T4 still need iodine supplementation, although the amount should be regulated on the basis of their L-T4 dosage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35121 Padua, Italy.
- Laboratory Medicine, Department of Medicine (DIMED), University of Padua, 35121 Padua, Italy.
- Department of Medical and Surgical Sciences (DiSCOG), University of Padua, 35100 Padua, Italy.
- Department of Paediatrics, Regional Centre for Newborn Screening, Diagnosis and Treatment of Inherited Metabolic Diseases and Congenital Endocrine Diseases, Azienda Ospedaliera Universitaria Integrata, 37134 Verona, Ita…
ORCID-Profile: Daniela Basso, Loris Bertazza, Susi Barollo, Marta Camilot, Caterina Mian
Zitieren
APA
Censi, S., Messina, G., Feligiotti, E., Clausi, C., Piva, I., Basso, D., Merante Boschin, I., Bertazza, L., Battheu, F., Barollo, S., Camilot, M., & Mian, C. (2025). Women with Autoimmune Thyroiditis Taking Levothyroxine During Pregnancy: Is Iodine Supplementation Needed?. Nutrients. https://doi.org/10.3390/nu17030542
Vancouver
Censi S, Messina G, Feligiotti E, Clausi C, Piva I, Basso D, et al. Women with Autoimmune Thyroiditis Taking Levothyroxine During Pregnancy: Is Iodine Supplementation Needed?. Nutrients. 2025. doi:10.3390/nu17030542
BibTeX
@article{Censi2025,
author = {Censi, Simona and Messina, Giulia and Feligiotti, Emma and Clausi, Cristina and Piva, Ilaria and Basso, Daniela and Merante Boschin, Isabella and Bertazza, Loris and Battheu, Fiammetta and Barollo, Susi and Camilot, Marta and Mian, Caterina},
title = {Women with Autoimmune Thyroiditis Taking Levothyroxine During Pregnancy: Is Iodine Supplementation Needed?},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17030542}
}
EUVIMED